1-8 of 8
Tomohiro Yabushita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PCYT1A Is a Metabolic Vulnerability in Monocytic Acute Myeloid Leukemia

Jakushin Nakahara, Keita Yamamoto, Tomohiro Yabushita, Takumi Chinen, Kei Ito, Yutaka Takeda, Daiju Kitagawa, Toshio Kitamura, Susumu Goyama
Journal: Blood
Blood (2024) 144 (Supplement 1): 2913.
https://doi.org/10.1182/blood-2024-202832
Published: 2024
Journal Articles

SETDB1 Suppresses Interferon Responses and NK Cell-Mediated Immunosurveillance Specifically in Monocytic AML

Yu-Hsuan Chang, Keita Yamamoto, Takeshi Fujino, Teh-Wei Wang, Emi Sugimoto, Wenyu Zhang, Tomohiro Yabushita, E. Christine Pietsch, Barbara A. Weir, Ramona Crescenzo, Glenn S. Cowley, Ricardo M. Attar, Ulrike Philippar, Yutaka Enomoto, Yoichi Imai, Toshio Kitamura, Susumu Goyama
Journal: Blood
Blood (2023) 142 (Supplement 1): 713.
https://doi.org/10.1182/blood-2023-177531
Published: 2023
Journal Articles

Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor Treatment

Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, Shuhei Asada, Keita Yamamoto, Naru Sato, Yutaka Enomoto, Yosuke Tanaka, Keiko Katoh, Kaori Saitoh, Takamasa Ishikawa, Hitoshi Sato, Tomoyoshi Soga, Yasuhito Nannya, Makoto Nakanishi, Daiju Kitagawa, Toshio Kitamura, Susumu Goyama
Journal: Blood
Blood (2022) 140 (Supplement 1): 8776–8777.
https://doi.org/10.1182/blood-2022-168499
Published: 2022
Journal Articles

High Pretreatment Plasma D-Dimer Levels Are Associated with Poor Prognosis in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphomas Treated with Immunochemotherapy

Atsushi Tanaka, MD, Yoshimitsu Shimomura, MD, Tomohiro Yabushita, MD, Takayuki Ishikawa
Journal: Blood
Blood (2018) 132 (Supplement 1): 4219.
https://doi.org/10.1182/blood-2018-99-115550
Published: 2018
Journal Articles

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

Tomohiro Yabushita, MD, Hayato Maruoka, PhD, Yoshimitsu Shimomura, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD PhD, Hisako Hashimoto, MD PhD, Takayuki Ishikawa, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 420.
https://doi.org/10.1182/blood.V130.Suppl_1.420.420
Published: 2017
Journal Articles

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

Yoshimitsu Shimomura, MD, Hayato Maruoka, PhD, Tomohiro Yabushita, MD, Hisako Hashimoto, Takayuki Ishikawa, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2000.
https://doi.org/10.1182/blood.V130.Suppl_1.2000.2000
Published: 2017
Journal Articles

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

Daisuke Kato, MD, Satoshi Yoshioka, MD, PhD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 2966.
https://doi.org/10.1182/blood.V128.22.2966.2966
Published: 2016
Journal Articles

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Yuichiro Ono, MD, Daisuke Kato, MD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Yukihiro Imai, MD, PhD, Hayato Maruoka, M.T, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 1480.
https://doi.org/10.1182/blood.V126.23.1480.1480
Published: 2015